The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Crohn’s Disease Treatment Market From 2026 To 2030?
The crohn’s disease treatment market size has experienced strong growth in recent years. It is anticipated to expand from $13.1 billion in 2025 to $13.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. In the past, this growth was primarily driven by factors such as increasing Crohn’s disease prevalence, a greater awareness of inflammatory bowel diseases, the expansion of hospital pharmacy networks, the availability of conventional anti-inflammatory drugs, and enhanced diagnostic capabilities.
The market for crohn’s disease treatment is projected to experience substantial expansion in the coming years. This market is anticipated to reach $18.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the forecast period include the expanding pipeline of biologics and small molecules, an increasing demand for personalized treatment options, the growing penetration of online pharmacies, rising healthcare spending in developing economies, and an emphasis on long-term disease management. Key trends observed within this period encompass the increasing acceptance of biologic therapies, a movement towards proactive and intensive treatment strategies, a greater emphasis on regimens that reduce steroid usage, the development of oral small-molecule treatments, and the broader availability through online and specialty pharmacy outlets.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
What Drivers Are Influencing The Crohn’s Disease Treatment Market?
The rising incidence of inflammatory bowel disorders is anticipated to boost the Crohn’s disease treatment market in the future. Inflammatory bowel disorders are chronic conditions characterized by inflammation of the gastrointestinal tract, which can affect any part of the digestive system, from the mouth to the anus, causing inflammation and damage. Treatments for Crohn’s disease aim to lessen intestinal inflammation, avert symptom flare-ups, and maintain remission. For example, data from September 2023, provided by the National Center for Biotechnology Information, a US-based government organization, indicated a comparable rise in the prevalence of Crohn’s disease and ulcerative colitis, with inflammatory bowel disease estimated at 825 cases per 100,000 people in 2023, specifically 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Consequently, the increasing occurrence of these conditions is stimulating the expansion of the Crohn’s disease treatment market.
Which Segments Are Included In The Analysis Of The Crohn’s Disease Treatment Market?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
Which Trends Are Impacting The Growth Of The Crohn’s Disease Treatment Market?
Key players in the crohn’s disease treatment market are developing and obtaining approvals for new medications, such as biosimilar ustekinumab, to deliver more effective and accessible therapeutic solutions for patients, ultimately elevating patient results and life quality. Biosimilar ustekinumab refers to a biological drug that is highly comparable to the original ustekinumab (a monoclonal antibody) used for managing autoimmune ailments. For example, in July 2024, Sandoz International GmbH, a pharmaceutical firm based in Switzerland, introduced Pyzchiva (ustekinumab) throughout Europe, establishing it as the inaugural ustekinumab biosimilar offered in all strengths, including a 130 mg vial specifically for Crohn’s disease. This drug is prescribed for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn’s disease, thereby strengthening Sandoz’s immunology portfolio while seeking to improve availability of affordable treatments for chronic inflammatory conditions.
Which Key Industry Participants Are Active In The Crohn’s Disease Treatment Market?
Major companies operating in the crohn’s disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.
Read the full crohn’s disease treatment market report here:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Crohn’s Disease Treatment Market?
North America was the largest region in the global Crohn’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Crohn’s Disease Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp
Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2026, By The Business Research Company
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Crohns Disease Cd Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model